Anticoagulant Reversal Medicine Market, Global Outlook and Forecast 2023-2029
Report Code: KNJ1551614 No. of Pages: 66 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Anticoagulant reversal medicine required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding.
This report aims to provide a comprehensive presentation of the global market for Anticoagulant Reversal Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulant Reversal Medicine. This report contains market size and forecasts of Anticoagulant Reversal Medicine in global, including the following market information:
Global Anticoagulant Reversal Medicine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Anticoagulant Reversal Medicine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Prothrombin Complex Concentrates Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anticoagulant Reversal Medicine include Amneal Pharmaceuticals, Bausch Health Companies, Boehringer Ingelheim, CSL, Fresenius Kabi, Octapharma, Perosphere Pharmaceuticals, Portola Pharmaceuticals and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anticoagulant Reversal Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anticoagulant Reversal Medicine Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Anticoagulant Reversal Medicine Market Segment Percentages, by Type, 2022 (%)
Prothrombin Complex Concentrates
Coagulation Factors
Monoclonal Antibodies
Phytonadione
Others
Global Anticoagulant Reversal Medicine Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Anticoagulant Reversal Medicine Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Anticoagulant Reversal Medicine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Anticoagulant Reversal Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anticoagulant Reversal Medicine revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anticoagulant Reversal Medicine revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amneal Pharmaceuticals
Bausch Health Companies
Boehringer Ingelheim
CSL
Fresenius Kabi
Octapharma
Perosphere Pharmaceuticals
Portola Pharmaceuticals
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anticoagulant Reversal Medicine, market overview.
Chapter 2: Global Anticoagulant Reversal Medicine market size in revenue.
Chapter 3: Detailed analysis of Anticoagulant Reversal Medicine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anticoagulant Reversal Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Anticoagulant Reversal Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anticoagulant Reversal Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anticoagulant Reversal Medicine Overall Market Size
2.1 Global Anticoagulant Reversal Medicine Market Size: 2022 VS 2029
2.2 Global Anticoagulant Reversal Medicine Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anticoagulant Reversal Medicine Players in Global Market
3.2 Top Global Anticoagulant Reversal Medicine Companies Ranked by Revenue
3.3 Global Anticoagulant Reversal Medicine Revenue by Companies
3.4 Top 3 and Top 5 Anticoagulant Reversal Medicine Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anticoagulant Reversal Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anticoagulant Reversal Medicine Players in Global Market
3.6.1 List of Global Tier 1 Anticoagulant Reversal Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Anticoagulant Reversal Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anticoagulant Reversal Medicine Market Size Markets, 2022 & 2029
4.1.2 Prothrombin Complex Concentrates
4.1.3 Coagulation Factors
4.1.4 Monoclonal Antibodies
4.1.5 Phytonadione
4.1.6 Others
4.2 By Type - Global Anticoagulant Reversal Medicine Revenue & Forecasts
4.2.1 By Type - Global Anticoagulant Reversal Medicine Revenue, 2018-2023
4.2.2 By Type - Global Anticoagulant Reversal Medicine Revenue, 2024-2029
4.2.3 By Type - Global Anticoagulant Reversal Medicine Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anticoagulant Reversal Medicine Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Anticoagulant Reversal Medicine Revenue & Forecasts
5.2.1 By Application - Global Anticoagulant Reversal Medicine Revenue, 2018-2023
5.2.2 By Application - Global Anticoagulant Reversal Medicine Revenue, 2024-2029
5.2.3 By Application - Global Anticoagulant Reversal Medicine Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Anticoagulant Reversal Medicine Market Size, 2022 & 2029
6.2 By Region - Global Anticoagulant Reversal Medicine Revenue & Forecasts
6.2.1 By Region - Global Anticoagulant Reversal Medicine Revenue, 2018-2023
6.2.2 By Region - Global Anticoagulant Reversal Medicine Revenue, 2024-2029
6.2.3 By Region - Global Anticoagulant Reversal Medicine Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Anticoagulant Reversal Medicine Revenue, 2018-2029
6.3.2 US Anticoagulant Reversal Medicine Market Size, 2018-2029
6.3.3 Canada Anticoagulant Reversal Medicine Market Size, 2018-2029
6.3.4 Mexico Anticoagulant Reversal Medicine Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Anticoagulant Reversal Medicine Revenue, 2018-2029
6.4.2 Germany Anticoagulant Reversal Medicine Market Size, 2018-2029
6.4.3 France Anticoagulant Reversal Medicine Market Size, 2018-2029
6.4.4 U.K. Anticoagulant Reversal Medicine Market Size, 2018-2029
6.4.5 Italy Anticoagulant Reversal Medicine Market Size, 2018-2029
6.4.6 Russia Anticoagulant Reversal Medicine Market Size, 2018-2029
6.4.7 Nordic Countries Anticoagulant Reversal Medicine Market Size, 2018-2029
6.4.8 Benelux Anticoagulant Reversal Medicine Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Anticoagulant Reversal Medicine Revenue, 2018-2029
6.5.2 China Anticoagulant Reversal Medicine Market Size, 2018-2029
6.5.3 Japan Anticoagulant Reversal Medicine Market Size, 2018-2029
6.5.4 South Korea Anticoagulant Reversal Medicine Market Size, 2018-2029
6.5.5 Southeast Asia Anticoagulant Reversal Medicine Market Size, 2018-2029
6.5.6 India Anticoagulant Reversal Medicine Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Anticoagulant Reversal Medicine Revenue, 2018-2029
6.6.2 Brazil Anticoagulant Reversal Medicine Market Size, 2018-2029
6.6.3 Argentina Anticoagulant Reversal Medicine Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anticoagulant Reversal Medicine Revenue, 2018-2029
6.7.2 Turkey Anticoagulant Reversal Medicine Market Size, 2018-2029
6.7.3 Israel Anticoagulant Reversal Medicine Market Size, 2018-2029
6.7.4 Saudi Arabia Anticoagulant Reversal Medicine Market Size, 2018-2029
6.7.5 UAE Anticoagulant Reversal Medicine Market Size, 2018-2029
7 Anticoagulant Reversal Medicine Companies Profiles
7.1 Amneal Pharmaceuticals
7.1.1 Amneal Pharmaceuticals Company Summary
7.1.2 Amneal Pharmaceuticals Business Overview
7.1.3 Amneal Pharmaceuticals Anticoagulant Reversal Medicine Major Product Offerings
7.1.4 Amneal Pharmaceuticals Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.1.5 Amneal Pharmaceuticals Key News & Latest Developments
7.2 Bausch Health Companies
7.2.1 Bausch Health Companies Company Summary
7.2.2 Bausch Health Companies Business Overview
7.2.3 Bausch Health Companies Anticoagulant Reversal Medicine Major Product Offerings
7.2.4 Bausch Health Companies Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.2.5 Bausch Health Companies Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Anticoagulant Reversal Medicine Major Product Offerings
7.3.4 Boehringer Ingelheim Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 CSL
7.4.1 CSL Company Summary
7.4.2 CSL Business Overview
7.4.3 CSL Anticoagulant Reversal Medicine Major Product Offerings
7.4.4 CSL Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.4.5 CSL Key News & Latest Developments
7.5 Fresenius Kabi
7.5.1 Fresenius Kabi Company Summary
7.5.2 Fresenius Kabi Business Overview
7.5.3 Fresenius Kabi Anticoagulant Reversal Medicine Major Product Offerings
7.5.4 Fresenius Kabi Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.5.5 Fresenius Kabi Key News & Latest Developments
7.6 Octapharma
7.6.1 Octapharma Company Summary
7.6.2 Octapharma Business Overview
7.6.3 Octapharma Anticoagulant Reversal Medicine Major Product Offerings
7.6.4 Octapharma Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.6.5 Octapharma Key News & Latest Developments
7.7 Perosphere Pharmaceuticals
7.7.1 Perosphere Pharmaceuticals Company Summary
7.7.2 Perosphere Pharmaceuticals Business Overview
7.7.3 Perosphere Pharmaceuticals Anticoagulant Reversal Medicine Major Product Offerings
7.7.4 Perosphere Pharmaceuticals Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.7.5 Perosphere Pharmaceuticals Key News & Latest Developments
7.8 Portola Pharmaceuticals
7.8.1 Portola Pharmaceuticals Company Summary
7.8.2 Portola Pharmaceuticals Business Overview
7.8.3 Portola Pharmaceuticals Anticoagulant Reversal Medicine Major Product Offerings
7.8.4 Portola Pharmaceuticals Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.8.5 Portola Pharmaceuticals Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Anticoagulant Reversal Medicine Major Product Offerings
7.9.4 Pfizer Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com